|
Gene
|
Female
|
Male
|
P-value
|
|---|
|
VDRa
|
9 (100%)
|
19 (90.5%)
|
0.483
|
|
VDRb
|
9 (100%)
|
19 (95.0%)
|
0.690
|
|
CLDNa
|
9 (100%)
|
14 (77.8%)
|
0.268
|
|
CLDNb
|
9 (100%)
|
14 (77.8%)
|
0.268
|
|
CasRa
|
8 (88.9%)
|
18 (94.7%)
|
0.575
|
|
CasRb
|
8 (88.9%)
|
18 (94.7%)
|
0.575
|
| |
Age < 60
|
Age ≥ 60
|
P-value
|
|---|
|
VDRa
|
22 (91.7%)
|
6 (100%)
|
0.634
|
|
VDRb
|
22 (95.6%)
|
6 (100%)
|
0.793
|
|
CLDNa
|
18 (81.8%)
|
5 (100%)
|
0.561
|
|
CLDNb
|
18 (81.8%)
|
5 (100%)
|
0.561
|
|
CasRa
|
20 (90.9%)
|
6 (100%)
|
0.611
|
|
CasRb
|
20 (90.9%)
|
6 (100%)
|
0.611
|
- In 30 recurrent stone formers, 21 were male (70%) and 24 were under 60 (80%). Hypermethylated for each target locus are presented
